Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) Director Sells $352,000.00 in Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) Director Lawson Macartney sold 16,000 shares of the business’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $22.00, for a total transaction of $352,000.00. Following the sale, the director now owns 47,965 shares of the company’s stock, valued at […]

Related Keywords

San Diego ,California ,United States ,Switzerland ,Blackrock ,Swiss ,Michaela Dinerman ,Lawson Macartney ,Roth Mkm ,Therapeutics Inc ,Securities Exchange Commission ,York Mellon Corp ,Swiss National Bank ,Dimensional Fund Advisors ,Maxim Group ,Therapeutics Company Profile ,Jpmorgan Chase Co ,Blackrock Inc ,Nasdaq ,Viking Therapeutics ,Get Rating ,Director Lawson Macartney ,Exchange Commission ,Therapeutics Stock Down ,National Bank ,New York Mellon Corp ,Fund Advisors ,Brian Lian ,Viking Therapeutics Daily ,Nasdaq Vktx ,Vktx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,